Regencell Bioscience (RGC) stock
RGC · Regencell Bioscience Holdings Limited · NASDAQ
What is the latest news on RGC stock?
RGC fell 4.21% to $4.21 on Nov 20, 2026. No RGC story in the last two days; the most recent is below.
INSIDERago
Director Lo William Wing Yan Dr exercised 36,001 units of Ordinary shares at a strike of $0.84, increasing direct ownership by 8% to 485,629 units (SEC Form 4)
4 - Regencell Bioscience Holdings Ltd (0001829667) (Issuer)
All RGC newsPrice$4.21-1.24 (-22.77%)
2026-08-202026-11-20
Financial highlights
Full financials- Net income, FY2026
- -$11.70M
- Cash
- $14.19M
For fiscal 2026 (ended Jun 30, 2026), from SEC filings. Not investment advice.
Latest news
25 items- INSIDERDirector Lo William Wing Yan Dr exercised 36,001 units of Ordinary shares at a strike of $0.84, increasing direct ownership by 8% to 485,629 units (SEC Form 4)4 - Regencell Bioscience Holdings Ltd (0001829667) (Issuer)
- SECSEC Form 144 filed by Regencell Bioscience Holdings Limited144 - Regencell Bioscience Holdings Ltd (0001829667) (Subject)
- SECSEC Form S-8 filed by Regencell Bioscience Holdings LimitedS-8 - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
- SECSEC Form 20-F filed by Regencell Bioscience Holdings Limited20-F - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
- INSIDERSEC Form 4 filed by Director Lo William Wing Yan Dr4 - Regencell Bioscience Holdings Ltd (0001829667) (Issuer)
- INSIDERSEC Form 4 filed by Director Hui Evana Yee Wah4 - Regencell Bioscience Holdings Ltd (0001829667) (Issuer)
- SECSEC Form 6-K filed by Regencell Bioscience Holdings Limited6-K - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
- SECSEC Form 424B5 filed by Regencell Bioscience Holdings Limited424B5 - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
- SECSEC Form 6-K filed by Regencell Bioscience Holdings Limited6-K - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
- SECSEC Form 6-K filed by Regencell Bioscience Holdings Limited6-K - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
- SECSEC Form 6-K filed by Regencell Bioscience Holdings Limited6-K - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
- SECSEC Form 6-K filed by Regencell Bioscience Holdings Limited6-K - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
- SECSEC Form 6-K filed by Regencell Bioscience Holdings Limited6-K - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
- SECSEC Form 6-K filed by Regencell Bioscience Holdings Limited6-K - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
- SECSEC Form 424B5 filed by Regencell Bioscience Holdings Limited424B5 - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
- SECSEC Form F-3ASR filed by Regencell Bioscience Holdings LimitedF-3ASR - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
- INSIDERSEC Form 3 filed by Regencell Bioscience Holdings Limited3 - Regencell Bioscience Holdings Ltd (0001829667) (Issuer)
- INSIDERSEC Form 3 filed by Regencell Bioscience Holdings Limited3 - Regencell Bioscience Holdings Ltd (0001829667) (Issuer)
- INSIDERSEC Form 3 filed by Regencell Bioscience Holdings Limited3 - Regencell Bioscience Holdings Ltd (0001829667) (Issuer)
- INSIDERSEC Form 3 filed by Regencell Bioscience Holdings Limited3 - Regencell Bioscience Holdings Ltd (0001829667) (Issuer)
- INSIDERSEC Form 3 filed by Regencell Bioscience Holdings Limited3 - Regencell Bioscience Holdings Ltd (0001829667) (Issuer)
- INSIDERSEC Form 3 filed by Regencell Bioscience Holdings Limited3 - Regencell Bioscience Holdings Ltd (0001829667) (Issuer)
- INSIDERSEC Form 3 filed by Regencell Bioscience Holdings Limited3 - Regencell Bioscience Holdings Ltd (0001829667) (Issuer)
- SECSEC Form 6-K filed by Regencell Bioscience Holdings Limited6-K - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
- SECSEC Form 20-F filed by Regencell Bioscience Holdings Limited20-F - Regencell Bioscience Holdings Ltd (0001829667) (Filer)
RGC rankings
News · 26 weeks4+200%
2026-05-312026-11-22
Mix490d
- SEC Filings2(50%)
- Other1(25%)
- Insider1(25%)
Activity · 52 weeks2411 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Regencell Bioscience Holdings Limited (RGC) is a Medicinal Chemicals and Botanical Products company listed on NASDAQ. In the last 30 days Quantisnow tracked 3 wire items for RGC, including 2 SEC filings and 1 insider trade. The most recent was published Nov 17, 2026.
RGC FAQ
7 questionsIs RGC profitable?
No. Regencell Bioscience Holdings Limited reported a net loss of $11.70M for fiscal 2026 (ended Jun 30, 2026).How much cash and debt does RGC have?
Regencell Bioscience Holdings Limited reported $14.19M in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does RGC stock trade?
Regencell Bioscience Holdings Limited (RGC) is listed on NASDAQ.What sector and industry is RGC in?
Regencell Bioscience Holdings Limited operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.When did Regencell Bioscience Holdings Limited go public?
Regencell Bioscience Holdings Limited (RGC) completed its IPO in 2021.What companies are similar to RGC?
Notable peers in the same industry include CIIT (Tianci International Inc.). Compare RGC side-by-side with any of them on Quantisnow.How can I track RGC on Quantisnow?
Quantisnow aggregates Regencell Bioscience Holdings Limited's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow RGC to receive live email and push alerts on every new disclosure.
Is something on this page wrong, or out of date? Request a change